Cures Start Here. Fred Hutchinson Cancer Research Center, home to three Nobel laureates, is an independent, nonprofit research institute based in Seattle. Its interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Its Vaccine and Infectious Disease Division, which is home to more than 70 faculty members, was established to facilitate and enhance the Hutch's efforts in infectious disease prevention and vaccine development. Careers Start Here.
The Newell and McElrath Labs in the Vaccine and Infectious Disease Division of the Fred Hutchinson Cancer Research Center are looking for a Post-Doctoral Fellow to support their joint work role to work on analysis of human cellular adaptive immune responses in the context of responses to vaccines and infectious disease.
The Newell Lab was originally established in 2012 at the Singapore Immunology Network, Singapore and then moved to the Vaccine and Infectious Disease Division of the Fred Hutchinson Cancer Research Center in August 2018 (publication list here .)
The McElrath Lab supports the many projects of Dr. Julie McElrath at the Fred Hutch since 1998. A leader in assay development, the Laboratory continues to improve and explore alternative methods, including systems biology approaches, multiparameter phenotyping and functional characterization of leukocyte subsets, host and viral genomics, as well as multiplex transcriptional, cytokine, and proteomic profiling.
We seek outstanding Postdoctoral fellows that are interested in diverse aspects of Vaccinology and Immunology, This would involve high dimensional profiling and adaptive receptor analysis of B and T cell responses and would involved the study of COVID-19, HIV and/or tuberculosis infection and vaccination. Our goal would be to understand the basis for the development of protective B and T cell responses to better understand how to formulate more or test the efficacy of the corresponding vaccines. This role would work closely with both labs to take advantage of synergistic technological expertise. This project would involve both lab work as well as heavy computational component and we will likely involved additional collaborators for both aspects.
Ph.D. (in Microbiology, Immunology, or protein-design are preferred)
Strong background in immunology, with emphasis on T and B cell immunity, is important
Ability to work independently within a very collaborative environment is critical, as are strong written, communication and organizational skills
Salary will be commensurate with appropriate experience
Applications must include:
Cover letter discussing your interest in this position
Statement of research interests and career goals
Names and contact information of at least three referees
Our Commitment to Diversity
We are proud to be an Equal Employment Opportunity (EEO) and Vietnam Era Veterans Readjustment Assistance Act (VEVRAA) Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability (physical or mental), marital or veteran status, genetic information, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. If due to a disability you need assistance/and or a reasonable accommodation during the application or recruiting process, please send a request to our Employee Services Center at email@example.com or by calling 206-667-4700.
At Fred Hutchinson Cancer Research Center, teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Researchers are discovering new ways to detect cancers earlier, improve treatments, and learn how to prevent cancers from growing. Although Fred Hutchinson opened its doors in 1975, its history began about 20 years before that. In 1962 Fred Hutchinson envisioned a center devoted to studying cancer, a disease that took his brother’s life. Today Fred Hutchinson is contributing to the next waves of breakthrough treatments and prevention strategies. Fred Hutchinson collaborates with the Seattle Cancer Alliance, the National Cancer Institute, and the University of Washington.